drugset / Trial / NCT01478022

To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20

NCT01478022

Phase 1 Completed 12 enrolled Parent Project, Italy
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the pharmacokinetics plasma profile of 3 treatments: ISO 20, IBU 200 and IBU and ISO combinations (200 +20) given in single dose. This study is being conducted to support the submission for new indication in treatment of the combinations of Isosorbide Dinitrate and Ibuprofen as a treatment for Duchenne muscular dystrophy.

Timeline

Start
2011-10
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 200 mg Oral
Comparator Isosorbide Dinitrate Other / unclassified 10 mg Oral